Exelixis, Inc. (EXEL)

43.96 -1.48 (-3.26%) USD  |  NASDAQ  |  Jan 16, 16:00
43.98 +0.02 (+0.05%) After-Hours: 20:00
More

Exelixis Cash from Discontinued Operations Adjustment (Quarterly)

Cash from Discontinued Operations Adjustment (Quarterly) Chart

View Cash from Discontinued Operations Adjustment (Quarterly) for EXEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Discontinued Operations Adjustment (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. --
ADMA Biologics, Inc. --
Aldeyra Therapeutics, Inc. --
Natera, Inc. --
Merck & Co., Inc. --